Global Vitamin D Testing Market Size, Share, Growth, Trends, Company Analysis and Forecast 2020 to 2027

The global vitamin D testing market size is expected to reach USD 1.6 billion by 2027.

Vitamin D is needed to maintain serum calcium and phosphate concentration to regularize the mineralization of bone and tooth. This vitamin D testing market analysis considers sales from both 25-hydroxyvitamin D testing and 1,25-dihydroxyvitamin D testing. Our analysis also considers the sales of vitamin D testing in Asia, Europe, North America, and ROW. In 2018, the 25-hydroxyvitamin D testing segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the increasing prevalence of vitamin D deficiency disorders will play a significant role in the 25-hydroxyvitamin D testing segment to maintain its market position. Also, our global vitamin D testing market report also looks at factors such as growing awareness on the importance of vitamin D, growing number of vitamin D deficiency-related disorders, and increasing geriatric population. However, product recalls posing challenge to the manufacturers, lack of awareness and limited healthcare services in developing regions, and lack of standard regulatory testing guidelines may hamper the growth of the vitamin D testing industry over the forecast period.

Rise in Number of Vitamin D Tests Performed Boosts Market Growth

• Rise in the prevalence of vitamin D deficiency, increase in the number of vitamin D tests performed, and changing lifestyles boost the growth of the global vitamin D testing market. The global vitamin D testing market is expected to expand at a CAGR of ~6% from 2019 to 2027.
• The market in Japan is likely to be driven by significant product launches by leading players, rise in the prevalence of osteoporosis, which is expected to affect over 13 million people annually, availability of reimbursements for these tests, and authority given to doctors to prescribe these tests.
• The need for vitamin D testing during pregnancy is increasing, owing to a rise in the prevalence of vitamin D deficiency in women. Deficiency of vitamin D during pregnancy can be attributed to the high requirement of vitamin D for fetal development. It is considered to be significantly common during pregnancy in high-risk groups, including vegetarians, women with limited sun exposure, and ethnic minorities, especially those with darker skin tones.
• The number of vitamin D tests performed annually has increased significantly in the past few years. Studies conducted in France indicate a dramatic increase in the number of vitamin D assay prescriptions. The number of tests performed in the country increased from 9,700 in 2008 to over 91,000 in 2013.

Growing number of vitamin D deficiency-related disorders

Rickets, a disease in which bone tissue does not properly mineralize, leading to soft bones and skeletal deformities in children is caused due to vitamin D deficiency. The deficiency in an adult causes mineralization problem in the skeleton, causing osteomalacia. Also, deficiency of vitamin D is related to increased risk of acquiring diabetes, immune system diseases, and neuropsychiatric disorder. The increasing prevalence of vitamin D deficiency-related disorders due to growing life expectancy will lead to the expansion of the global vitamin D testing market at a CAGR of almost 5% during the forecast period.

An increasing number of infections and autoimmune diseases

Vitamin D plays a key role in managing the immune system, as vitamin D receptor is expressed in all immune cells that include B cells, T cells, and antigen-presenting cells. These immunological cells can synthesize active vitamin D metabolites, thereby helping vitamin D to modulate the innate and adaptive immune responses. Vitamin D deficiency is linked with increased autoimmunity and susceptibility to infectious diseases caused by organisms such as bacteria, virus, fungi, and parasites. The increasing number of infections and autoimmune diseases is expected to have a positive impact on the overall market growth.

Asia Pacific Market to Grow at Rapid Pace

• North America held a major share of the global vitamin D testing market in terms of revenue in 2018. The region is projected to dominate the global market during the forecast period. Rise in the prevalence of vitamin D deficiency, increase in prescriptions of vitamin D tests, surge in the aging population, and rise in the prevalence of vitamin D deficiency among the adult population boost the growth of the market in North America.
• Europe is anticipated to be the second-largest market in terms of share and revenue during the forecast period. Vitamin D deficiency is a public health issue in Germany. It is significantly prevalent in the adult as well as younger population. Moreover, various studies conducted in Germany indicate that, the average intake of vitamin D does not meet the recommended daily intake levels. These factors increase the number of vitamin D tests performed in the country, consequently fueling the growth of the market.
• The vitamin D testing market in Asia Pacific is expected to expand at a high CAGR of ~7% during the forecast period. Growth of the market in the region is attributed to increase in the geriatric population, rise in the prevalence of vitamin D deficiency, changing reimbursement scenario for these tests, and increase in focus of market players on strengthening their presence in developing economies.

Competitive Landscape

With the presence of a few major players, the global vitamin D testing market is fairly concentrated. This robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading vitamin D testing companies, that include Abbott Laboratories, bioMérieux SA, Danaher Corp., F. Hoffmann-La Roche Ltd., and Siemens Healthcare GmbH.

Also, the vitamin D testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The global vitamin D testing market has been segmented as follows:

• Vitamin D Testing Market by Test
  • 25-Hydroxy D Vitamin
  • 1,25-Dihydroxy D Vitamin
• Vitamin D Testing Market by Technique
  • Radioimmunoassay
  • ELISA
  • HPLC
  • LC-MS
  • Others
• Vitamin D Testing Market by Patient
  • Adult
  • Pediatric
• Vitamin D Testing Market by Indication
  • Osteoporosis
  • Rickets
  • Thyroid Disorders
  • Malabsorption
  • Vitamin D Deficiency
  • Others
• Vitamin D Testing Market by End User
  • Hospitals
  • Diagnostic Laboratories
  • Home Care
  • Point-of-care
  • Others
• Vitamin D Testing Market by Region
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • Australia
    • India
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Israel
    • Rest of Middle East & Africa